Communication Equipment
Compare Stocks
4 / 10Stock Comparison
BKTI vs SIFY vs MNDO vs HCTI
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Software - Application
Medical - Healthcare Information Services
BKTI vs SIFY vs MNDO vs HCTI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Communication Equipment | Telecommunications Services | Software - Application | Medical - Healthcare Information Services |
| Market Cap | $351M | $1.15B | $21M | $49K |
| Revenue (TTM) | $86M | $41.45B | $19M | $13M |
| Net Income (TTM) | $14M | $-1.50B | $3M | $-6M |
| Gross Margin | 48.8% | 34.2% | 51.0% | 13.1% |
| Operating Margin | 18.6% | 5.2% | 10.7% | -45.2% |
| Forward P/E | 26.5x | — | 7.8x | — |
| Total Debt | $2M | $39.51B | $929K | $3M |
| Cash & Equiv. | $23M | $5.00B | $8M | $20K |
BKTI vs SIFY vs MNDO vs HCTI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| BK Technologies Cor… (BKTI) | 100 | 636.7 | +536.7% |
| Sify Technologies L… (SIFY) | 100 | 74.3 | -25.7% |
| MIND C.T.I. Ltd (MNDO) | 100 | 30.3 | -69.7% |
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BKTI vs SIFY vs MNDO vs HCTI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BKTI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 12.5%, EPS growth 52.9%, 3Y rev CAGR 19.1%
- 336.1% 10Y total return vs SIFY's 141.0%
- Lower volatility, beta 1.24, Low D/E 3.5%, current ratio 4.21x
- 12.5% revenue growth vs HCTI's -64.8%
SIFY is the clearest fit if your priority is momentum.
- +264.2% vs HCTI's -99.9%
MNDO is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.07, yield 21.6%
- Beta 0.07, yield 21.6%, current ratio 3.83x
- Better valuation composite
- Beta 0.07 vs HCTI's 3.07
HCTI lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.5% revenue growth vs HCTI's -64.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 15.7% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.07 vs HCTI's 3.07 | |
| Dividends | 21.6% yield, vs SIFY's 0.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +264.2% vs HCTI's -99.9% | |
| Efficiency (ROA) | 21.9% ROA vs HCTI's -60.0%, ROIC 50.5% vs -6.3% |
BKTI vs SIFY vs MNDO vs HCTI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BKTI vs SIFY vs MNDO vs HCTI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BKTI leads in 3 of 6 categories
MNDO leads 1 • SIFY leads 0 • HCTI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BKTI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SIFY is the larger business by revenue, generating $41.4B annually — 3202.7x HCTI's $13M. BKTI is the more profitable business, keeping 15.7% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $86M | $41.4B | $19M | $13M |
| EBITDAEarnings before interest/tax | $16M | $8.1B | $2M | -$6M |
| Net IncomeAfter-tax profit | $14M | -$1.5B | $3M | -$6M |
| Free Cash FlowCash after capex | $18M | $0 | $4M | -$12M |
| Gross MarginGross profit ÷ Revenue | +48.8% | +34.2% | +51.0% | +13.1% |
| Operating MarginEBIT ÷ Revenue | +18.6% | +5.2% | +10.7% | -45.2% |
| Net MarginNet income ÷ Revenue | +15.7% | -3.6% | +13.4% | -48.9% |
| FCF MarginFCF ÷ Revenue | +21.4% | -9.2% | +20.9% | -94.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.0% | +2.5% | -6.0% | +44.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.0% | -3.7% | -23.4% | -63.8% |
Valuation Metrics
MNDO leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 7.8x trailing earnings, MNDO trades at a 72% valuation discount to BKTI's 27.3x P/E. On an enterprise value basis, MNDO's 5.7x EV/EBITDA is more attractive than BKTI's 20.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $351M | $1.1B | $21M | $49,177 |
| Enterprise ValueMkt cap + debt − cash | $329M | $1.5B | $13M | $3M |
| Trailing P/EPrice ÷ TTM EPS | 27.30x | -119.57x | 7.77x | -0.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.46x | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | 0.24x | — | — | — |
| EV / EBITDAEnterprise value multiple | 20.61x | 18.19x | 5.68x | — |
| Price / SalesMarket cap ÷ Revenue | 4.07x | 2.73x | 1.06x | 0.00x |
| Price / BookPrice ÷ Book value/share | 8.27x | 4.65x | 0.90x | — |
| Price / FCFMarket cap ÷ FCF | 19.06x | — | 5.20x | — |
Profitability & Efficiency
BKTI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
BKTI delivers a 35.0% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-113 for HCTI. BKTI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), BKTI scores 7/9 vs HCTI's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +35.0% | -7.7% | +11.9% | -112.9% |
| ROA (TTM)Return on assets | +21.9% | -1.8% | +8.6% | -60.0% |
| ROICReturn on invested capital | +50.5% | +3.3% | +8.6% | -6.3% |
| ROCEReturn on capital employed | +35.7% | +4.4% | +7.8% | — |
| Piotroski ScoreFundamental quality 0–9 | 7 | 3 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.04x | 1.96x | 0.04x | — |
| Net DebtTotal debt minus cash | -$21M | $34.5B | -$7M | $3M |
| Cash & Equiv.Liquid assets | $23M | $5.0B | $8M | $20,000 |
| Total DebtShort + long-term debt | $2M | $39.5B | $929,000 | $3M |
| Interest CoverageEBIT ÷ Interest expense | 60.33x | 0.82x | — | -3.79x |
Total Returns (Dividends Reinvested)
BKTI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BKTI five years ago would be worth $41,093 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +264.2% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors BKTI at 91.4% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.9% | +29.2% | -13.7% | -93.7% |
| 1-Year ReturnPast 12 months | +121.5% | +264.2% | -34.8% | -99.9% |
| 3-Year ReturnCumulative with dividends | +600.9% | +113.4% | -24.2% | -100.0% |
| 5-Year ReturnCumulative with dividends | +310.9% | -12.1% | -35.0% | -100.0% |
| 10-Year ReturnCumulative with dividends | +336.1% | +141.0% | +66.7% | -100.0% |
| CAGR (3Y)Annualised 3-year return | +91.4% | +28.8% | -8.8% | -96.0% |
Risk & Volatility
Evenly matched — BKTI and MNDO each lead in 1 of 2 comparable metrics.
Risk & Volatility
MNDO is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BKTI currently trades 95.4% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.24x | 1.33x | 0.07x | 3.07x |
| 52-Week HighHighest price in past year | $98.42 | $17.85 | $1.64 | $7410.00 |
| 52-Week LowLowest price in past year | $36.17 | $4.15 | $0.98 | $0.29 |
| % of 52W HighCurrent price vs 52-week peak | +95.4% | +89.0% | +61.6% | +0.0% |
| RSI (14)Momentum oscillator 0–100 | 56.4 | 56.7 | 27.4 | 36.7 |
| Avg Volume (50D)Average daily shares traded | 59K | 56K | 37K | 572K |
Analyst Outlook
Evenly matched — BKTI and MNDO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BKTI as "Buy", SIFY as "Buy". MNDO is the only dividend payer here at 21.61% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | — |
| Price TargetConsensus 12-month target | — | — | — | — |
| # AnalystsCovering analysts | 1 | 1 | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +21.6% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | — |
| Dividend / ShareAnnual DPS | — | $0.36 | $0.22 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | 0.0% | +0.6% | 0.0% |
BKTI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MNDO leads in 1 (Valuation Metrics). 2 tied.
BKTI vs SIFY vs MNDO vs HCTI: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is BKTI or SIFY or MNDO or HCTI a better buy right now?
For growth investors, BK Technologies Corporation (BKTI) is the stronger pick with 12.
5% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). MIND C. T. I. Ltd (MNDO) offers the better valuation at 7. 8x trailing P/E, making it the more compelling value choice. Analysts rate BK Technologies Corporation (BKTI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BKTI or SIFY or MNDO or HCTI?
On trailing P/E, MIND C.
T. I. Ltd (MNDO) is the cheapest at 7. 8x versus BK Technologies Corporation at 27. 3x.
03Which is the better long-term investment — BKTI or SIFY or MNDO or HCTI?
Over the past 5 years, BK Technologies Corporation (BKTI) delivered a total return of +310.
9%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: BKTI returned +336. 1% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BKTI or SIFY or MNDO or HCTI?
By beta (market sensitivity over 5 years), MIND C.
T. I. Ltd (MNDO) is the lower-risk stock at 0. 07β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 4354% more volatile than MNDO relative to the S&P 500. On balance sheet safety, BK Technologies Corporation (BKTI) carries a lower debt/equity ratio of 4% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — BKTI or SIFY or MNDO or HCTI?
By revenue growth (latest reported year), BK Technologies Corporation (BKTI) is pulling ahead at 12.
5% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: BK Technologies Corporation grew EPS 52. 9% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, BKTI leads at 19. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BKTI or SIFY or MNDO or HCTI?
BK Technologies Corporation (BKTI) is the more profitable company, earning 15.
7% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 15. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BKTI leads at 18. 6% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MNDO leads at 51. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — BKTI or SIFY or MNDO or HCTI?
In this comparison, MNDO (21.
6% yield) pays a dividend. BKTI, SIFY, HCTI do not pay a meaningful dividend and should not be held primarily for income.
08Is BKTI or SIFY or MNDO or HCTI better for a retirement portfolio?
For long-horizon retirement investors, MIND C.
T. I. Ltd (MNDO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 07), 21. 6% yield). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MNDO: +66. 7%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BKTI and SIFY and MNDO and HCTI?
These companies operate in different sectors (BKTI (Technology) and SIFY (Communication Services) and MNDO (Technology) and HCTI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BKTI is a small-cap quality compounder stock; SIFY is a small-cap quality compounder stock; MNDO is a small-cap deep-value stock; HCTI is a small-cap quality compounder stock. MNDO pays a dividend while BKTI, SIFY, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.